CeriBell (NASDAQ:CBLL - Get Free Report)'s stock had its "buy" rating restated by analysts at Canaccord Genuity Group in a research report issued to clients and investors on Wednesday,Benzinga reports. They currently have a $33.00 price target on the stock. Canaccord Genuity Group's price objective indicates a potential upside of 42.00% from the stock's previous close.
CBLL has been the topic of a number of other research reports. TD Cowen increased their price target on shares of CeriBell from $31.00 to $36.00 and gave the company a "buy" rating in a report on Monday, December 9th. Canaccord Genuity Group began coverage on shares of CeriBell in a report on Tuesday, November 5th. They set a "buy" rating and a $30.00 price target on the stock. William Blair began coverage on shares of CeriBell in a report on Tuesday, November 5th. They set an "outperform" rating on the stock. JPMorgan Chase & Co. began coverage on shares of CeriBell in a report on Tuesday, November 5th. They set an "overweight" rating and a $32.00 price target on the stock. Finally, Bank of America began coverage on shares of CeriBell in a report on Tuesday, November 5th. They issued a "buy" rating and a $32.00 target price on the stock. Six analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has a consensus rating of "Buy" and an average price target of $32.60.
Read Our Latest Report on CBLL
CeriBell Stock Performance
CBLL traded down $0.52 during midday trading on Wednesday, reaching $23.24. The company's stock had a trading volume of 375,746 shares, compared to its average volume of 193,006. CeriBell has a 1 year low of $18.69 and a 1 year high of $32.75. The company's 50-day simple moving average is $23.27.
CeriBell (NASDAQ:CBLL - Get Free Report) last posted its quarterly earnings results on Tuesday, February 25th. The company reported ($0.40) EPS for the quarter, missing analysts' consensus estimates of ($0.32) by ($0.08). The firm had revenue of $18.53 million for the quarter, compared to analysts' expectations of $17.55 million. Equities research analysts predict that CeriBell will post -2.46 EPS for the current year.
Institutional Trading of CeriBell
Several institutional investors and hedge funds have recently modified their holdings of CBLL. FMR LLC purchased a new position in CeriBell during the fourth quarter valued at $128,120,000. TPG GP A LLC purchased a new position in CeriBell during the fourth quarter valued at $102,677,000. Red Tree Management LLC purchased a new position in CeriBell during the fourth quarter valued at $57,083,000. Yu Fan purchased a new position in CeriBell during the fourth quarter valued at $31,631,000. Finally, ABG WTT Global Life Science Capital Partners GP Ltd purchased a new position in CeriBell during the fourth quarter valued at $28,160,000.
CeriBell Company Profile
(
Get Free Report)
We are a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting.
Further Reading
Before you consider CeriBell, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CeriBell wasn't on the list.
While CeriBell currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
